Multidrug resistance

The natural substance researcher Prof Rolf Müller has been awarded the 2016 PHOENIX Pharmaceutical Science Award worth 10,000 euro. Müller heads the Helmholtz Institute for Pharmaceutical Research

Multidrug-resistant tuberculosis is continuously spreading. Treatment has many side effects, is costly and, above all, lengthy. Since May 2016, the World Health Organisation (WHO) has recommended a

An international team of scientists has had unexpected success in treating tuberculosis with a ß-lactam antibiotic that is approved for other indications. DZIF scientists from the Research Center

The mcr-1 gene makes gut bacteria insensitive to the last-resort antibiotic colistin. Especially in hospitals, colistin is used as a last treatment option for infections with dreaded multidrug

Salmonella infections in the bloodstream, caused by Salmonella enterica bacteria, are still the cause of many deaths in southern regions and Southeast Asia. Children between the age of two and five

World Tuberculosis Day on 24 March is a reminder to the public that 1.5 people still die of tuberculosis (TB) every year. The rise of multidrug-resistant strains is particularly problematic, currently

Scientists led by the Leibniz Research Center Borstel, the Institute of Microbiology and Laboratory Diagnostics in Gauting, the Institute of Medical Microbiology of the University of Zurich and the

Researchers from the German Center for Infection Research (DZIF) and the University of Giessen have shown that the gene for resistance to colistin, which was recently discovered in China, also exists

Infectious diseases are a leading cause of death worldwide. Current problems such as antibiotic resistance, declining vaccination rates and emerging infections like Ebola present scientists and

According to figures of the World Health Organization, some 8.7 million people contracted tuberculosis in 2012 and this disease is fatal for approximately 1.3 million people throughout the world each